PolyNovo

PNV.AX

Tags: AU Healthcare Medical - Devices

PolyNovo Limited Price (PNV.AX)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

700,382,751

(2.3272)%

Market Cap of PolyNovo (PNV.AX)

Market cap:

As of , PNV.AX has a market cap of . This makes PNV.AX the 190th most valuable company in the AU by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing hernia devices for hernia repair and tissue reinforcement products; NovoSorb Dermal Beta Cell Implant to host pancreatic islets in the skin; and NovoSorb drug elution depots. The company was formerly known as Calzada Limited and changed... Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $1.125-2.78
Market Cap 870.46M
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Medical - Devices

ceo: Mr. Swami Raote BPHARM, M.B.A.
IPO Date: November, 30, 1998
Country: AU
Currency: AUD
Headquaters: Port Melbourne, VIC
Employees: 282

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: